Literature DB >> 3959887

Hepatic gluconeogenesis from alanine: 13C nuclear magnetic resonance methodology for in vivo studies.

M E Stromski, F Arias-Mendoza, J R Alger, R G Shulman.   

Abstract

This paper describes an experimental protocol designed to optimize 13C NMR spectra from the liver of the living anesthetized rat at 1.9 T. The protocol involves the use of a Helmholtz NMR coil which is positioned around the liver after surgical exposure. 1H decoupling is facilitated by double tuning this coil to both the 1H and the 13C frequencies. The protocol was shown to be suitable for studying the hepatic metabolism of 13C-labeled substrates in vivo by investigating the metabolism of [3-13C]alanine. Labeled glucose, glutamate, glutamine, and aspartate were formed and detected by 13C NMR in vivo in this experiment. The labeling patterns in these metabolites provided evidence that the major flow of alanine carbon into the Krebs cycle is via the pyruvate carboxylase reaction rather than through pyruvate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959887     DOI: 10.1002/mrm.1910030105

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

Review 1.  Magnetic resonance spectroscopy in the recognition of metabolic disease.

Authors:  R D Griffiths; R H Edwards
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Trap Design and Construction for High-Power Multinuclear Magnetic Resonance Experiments.

Authors:  Joseph V Rispoli; Ivan E Dimitrov; Sergey Cheshkov; Craig Malloy; Steven M Wright; Mary P McDougall
Journal:  Concepts Magn Reson Part B Magn Reson Eng       Date:  2016-11-17       Impact factor: 1.176

3.  In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate.

Authors:  Simon Hu; Albert P Chen; Matthew L Zierhut; Robert Bok; Yi-Fen Yen; Marie A Schroeder; Ralph E Hurd; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron
Journal:  Mol Imaging Biol       Date:  2009-05-08       Impact factor: 3.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.